NR4A1, 2, 3 - An orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis

Histology and Histopathology

Volumn 21, Issue 4-6, 2006, Pages 533-540

  Li, Qi Xiang ^a   Ke, N ^a   Sundaram, R ^a   Wong Staal, F ^a  

^a Immusol Inc   (United States)

Author keywords

Apoptosis; Carcinogenesis; NR4A1; NR4A2; NR4A3; Transformation

Indexed keywords

3,3' DIINDOYLMETHANE DERIVATIVE; ANTINEOPLASTIC AGENT; GROWTH FACTOR; HORMONE RECEPTOR; LIGAND; NR4A1 RECEPTOR; NR4A2 RECEPTOR; NR4A3 RECEPTOR; PROTEIN BCL 2; STEROID RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER; CARCINOGENESIS; CARCINOGENICITY; CELL MATURATION; CELL NUCLEUS; CELL SURVIVAL; CELL TRANSFORMATION; DRUG INDICATION; DRUG TARGETING; GENE EXPRESSION; GENE INACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MITOCHONDRION; MITOGENESIS; NONHUMAN; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR BINDING; REVIEW; SERUM; THYMOCYTE; TRANSCRIPTION INITIATION; TRANSGENIC ANIMAL;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

ANIMALIA;

EID: 33645566549     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Baker K.D., Shewchuk L.M., Kozlova T., Makishima M., Hassell A., Wisely B., Caravella J.A., Lambert M.H., Reinking J.L. and Krause H. (2003). The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway. Cell 113, 731-742.
2. Boylan M.O., Athanassiou M., Houle B., Wang Y. and Zarbl H. (1996). Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line. Cell Growth Differ 7, 725-735.
3. Bras A., Albar J.P., Leonardo E., de Buitrago G.G. and Martinez A.C. (2000). Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells. Cell. Death Differ. 7, 262-271.
4. Calnan B.J., Szychowski S., Chan F.K., Cado D. and Winoto A. (1995). A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 3, 273-282.
5. Castillo S.O., Baffi J.S., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., and Nikodem V.M. (1998). Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell Neurosci. 11, 36-46.
6. Cheng L.E., Chan F.K., Cado D. and Winoto A. (1997). Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 16, 1865-1875.
7. Chintharlapalli S., Burghardt R., Papineni S., Ramaiah S., Yoon K. and Safe S. (2005). Activation of Nur77 by selected 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways. J. Biol. Chem. 280, 24903-24914.
8. Codina A., Benoit G., Gooch J.T., Neuhaus D., Perlmann T. and Schwabe J.W. (2004). Identification of a novel co-regulator interaction surface on the ligand binding domain of Nurr1 using NMR footprinting. J. Biol. Chem. 279, 53338-53345.
9. Davis I.J. and Lau L.F. (1994). Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands. Mol. Cell Biol. 14, 3469-3483.
10. DeYoung R.A., Baker J.C., Cado D. and Winoto A. (2003). The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. J. Biol. Chem.278, 47104-47109.
11. Enmark E. and Gustafsson J.A. (1996). Orphan nuclear receptors - the first eight years. Mol. Endocrinol. 10, 1293-1307.
12. Fernandez P.M., Brunel F., Jimenez M.A., Saez J.M., Cereghini S. and Zakin M.M. (2000). Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis. Endocrinology 141, 2392-2400.
13. Forman B.M., Umesono K., Chen J. and Evans R.M. (1995). Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81, 541-550.
14. Hirata Y., Kiuchi K., Chen H.C., Milbrandt J. and Guroff G. (1993). The phosphorylation and DNA binding of the DNA-binding domain of the orphan nuclear receptor NGFI-B. J. Biol. Chem. 268, 24808-24812.
15. Hsu H.C., Zhou T. and Mountz J.D. (2004). Nur77 family of nuclear hormone receptors. Curr. Drug Targets Inflamm. Allergy 3, 413-423.
16. Katagiri Y., Hirata Y., Milbrandt J. and Guroff G. (1997). Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor. J. Biol. Chem. 272, 31278-31284.
17. Katagiri Y., Takeda K., Yu Z.X., Ferrans V.J., Ozato K. and Guroff G. (2000). Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat. Cell Biol. 2, 435-440.
18. Ke N., Claassen G., Yu D.H., Albers A., Fan W., Tan P., Grifman M., Hu X., Defife K. and Nguy V. (2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res. 64, 8208-8212.
19. Kolluri S.K., Bruey-Sedano N., Cao X., Lin B., Lin F., Han Y.H., Dawson M.I. and Zhang X.K. (2003). Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol. Cell Biol. 23, 8651-8667.
20. Labelle Y., Bussieres J., Courjal F. and Goldring M.B. (1999). The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator. Oncogene 18, 3303-3308.
21. Law S.W., Conneely O.M., DeMayo F.J. and O'Malley B.W. (1992). Identification of a new brain-specific transcription factor, NURR1. Mol. Endocrinol. 6, 2129-2135.
22. Le W., Conneely O.M., He Y., Jankovic J. and Appel S.H. (1999). Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J. Neurochem. 73, 2218-2221.
23. Le W.D., Xu P., Jankovic J., Jiang H., Appel S.H., Smith R.G. and Vassilatis D.K. (2003). Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet. 33, 85-89.
24. Lee M.A., Lee H.S., Cho K.G., Jin B.K., Sohn S., Lee Y.S., Ichinose H., and Kim S.U. (2002). Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins. Neurosci. Lett. 333, 74-78.
25. Lee S.L., Wesselschmidt R.L., Linette G.P., Kanagawa O., Russell J.H., and Milbrandt J. (1995). Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 269, 532-535.
26. Li H., Kolluri S.K., Gu J., Dawson M.I., Cao X., Hobbs P.D., Lin B., Chen G., Lu J. and Lin F. (2000). Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289, 1159-1164.
27. Li Q.X., Tan P., Ke N. and Wong-Staal F. (2005). Ribozyme technology and its application in cancer gene target identification and validation. In: Genomics in cancer drug development. Hampton G. and Silkora K. (eds). Academic Press (in press).
28. Li Y. and Lau L.F. (1997). Adrenocorticotropic hormone regulates the activities of the orphan nuclear receptor Nur77 through modulation of phosphorylation. Endocrinology 138, 4138-4146.
29. Li Y., Lin B., Agadir A., Liu R., Dawson M.I., Reed J.C., Fontana J.A., Bost F., Hobbs P D. and Zheng Y. (1998). Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol. Cell Biol. 18, 4719-4731.
30. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X., Dawson M.I., Reed J.C. and Zhang X.K. (2004). Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116, 527-540.
31. Maira M., Martens C., Philips A. and Drouin J. (1999). Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell Biol. 19, 7549-7557.
32. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. and Evans R.M. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
33. Masuyama N., Oishi K., Mori Y., Ueno T., Takahama Y. and Gotoh Y. (2001). Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J. Biol. Chem. 276, 32799-32805.
34. McEvoy A.N., Murphy E.A., Ponnio T., Conneely O.M., Bresnihan B., FitzGerald O. and Murphy E.P. (2002). Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5′-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue. J. Immunol. 168, 2979-2987.
35. Meinke G. and Sigler P.B. (1999). DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B. Nature Struct. Biol. 6, 471-477.
36. Paulsen R.F., Granas K., Johnsen H., Rolseth V. and Sterri S. (1995). Three related brain nuclear receptors, NGFI-B, Nurr1, and NOR-1, as transcriptional activators. J. Mol. Neurosci. 6, 249-255.
37. Pekarsky Y., Hallas C., Palamarchuk A., Koval A., Bullrich F., Hirata Y., Bichi R., Letofsky J. and Croce C.M. (2001). Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl. Acad. Sci. USA 98, 3690-3694.
38. Perlmann T. and Jansson L. (1995). A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 9, 769-782.
39. Ponnio T., Burton Q., Pereira F.A., Wu D.K. and Conneely O M. (2002). The nuclear receptor Nor-1 is essential for proliferation of the semicircular canals of the mouse inner ear. Mol. Cell Biol. 22, 935-945.
40. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P. and Conneely O.M. (1998). Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95, 4013-4018.
41. Suzuki S., Suzuk N., Mirtsos C., Horacek T., Lye E., Noh S.K., Ho A., Bouchard D., Mak T.W. and Yeh W.C. (2003). Nur77 as a survival factor in tumor necrosis factor signaling. Proc. Natl. Acad. Sci. USA 100, 8276-8280.
42. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N.P. and Perlmann T. (2003). Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423, 555-560.
43. Weih F., Ryseck R.P., Chen L. and Bravo R. (1996). Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. USA 93, 5533-5538.
44. Wilson T.E., Fahrner T.J., Johnston M. and Milbrandt J. (1991). Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 252, 1296-1300.
45. Winoto A. and Littman D.R. (2002). Nuclear hormone receptors in T lymphocytes. Cell 109 Suppl, S57-66.
46. Wu Q., Li Y., Liu R., Agadir A., Lee M.O., Liu Y. and Zhang X. (1997). Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J. 16, 1656-1669.
47. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L. and Perlmann T. (1997). Dopamine neuron agenesis in Nurr1-deficient mice. Science 276, 248-250.
48. Zetterstrom R.H., Solomin L., Mitsiadis T., Olson L. and Perlmann T. (1996). Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol. Endocrinol. 10, 1656-1666.
49. Zhang J., DeYoung A., Kasler H.G., Kabra N.H., Kuang A.A., Diehl G., Sohn S.J., Bishop C. and Winoto A. (1999). Receptor-mediated apoptosis in T lymphocytes. Cold Spring Harb. Symp. Quant. Biol. 64, 363-371.